Common Stock, Shares, Outstanding of Anixa Biosciences Inc from 31 Oct 2010 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Anixa Biosciences Inc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Oct 2010 to 31 Jan 2026.
  • Anixa Biosciences Inc Common Stock, Shares, Outstanding for the quarter ending 31 Jan 2026 was 33,463,440, a 3.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 33,463,440 +1,266,578 +3.9% 31 Jan 2026 10-Q 09 Mar 2026 2026 Q1
Q3 2025 33,013,829 +816,967 +2.5% 31 Oct 2025 10-Q 09 Mar 2026 2026 Q1
Q2 2025 32,822,109 +675,649 +2.1% 31 Jul 2025 10-Q 10 Sep 2025 2025 Q3
Q1 2025 32,211,092 +204,632 +0.64% 30 Apr 2025 10-Q 28 May 2025 2025 Q2
Q4 2024 32,196,862 +442,487 +1.4% 31 Jan 2025 10-Q 11 Mar 2025 2025 Q1
Q3 2024 32,196,862 +1,051,643 +3.4% 31 Oct 2024 10-K 12 Jan 2026 2025 FY
Q2 2024 32,146,460 +1,128,690 +3.6% 31 Jul 2024 10-Q 06 Sep 2024 2024 Q3
Q1 2024 32,006,460 +1,047,795 +3.4% 30 Apr 2024 10-Q 04 Jun 2024 2024 Q2
Q4 2023 31,754,375 +831,545 +2.7% 31 Jan 2024 10-Q 12 Mar 2024 2024 Q1
Q3 2023 31,145,219 +231,317 +0.75% 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q2 2023 31,017,770 +364,352 +1.2% 31 Jul 2023 10-Q 06 Sep 2023 2023 Q3
Q1 2023 30,958,665 +803,957 +2.7% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 30,922,830 +790,511 +2.6% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 30,913,902 +863,008 +2.9% 31 Oct 2022 10-K 16 Jan 2024 2023 FY
Q2 2022 30,653,418 +703,513 +2.3% 31 Jul 2022 10-Q 09 Sep 2022 2022 Q3
Q1 2022 30,154,708 -1,295,197 -4.1% 30 Apr 2022 10-Q 10 Jun 2022 2022 Q2
Q4 2021 30,132,319 +3,953,197 +15% 31 Jan 2022 10-Q 11 Mar 2022 2022 Q1
Q3 2021 30,050,894 +5,802,199 +24% 31 Oct 2021 10-K 04 Jan 2023 2022 FY
Q2 2021 29,949,905 +6,296,151 +27% 31 Jul 2021 10-Q 01 Sep 2021 2021 Q3
Q1 2021 31,449,905 +9,970,570 +46% 30 Apr 2021 10-Q 10 Jun 2021 2021 Q2
Q4 2020 26,179,122 +5,337,813 +26% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q1
Q3 2020 24,248,695 +3,916,941 +19% 31 Oct 2020 10-K 04 Jan 2022 2022 FY
Q2 2020 23,653,754 +3,490,903 +17% 31 Jul 2020 10-Q 08 Sep 2020 2020 Q3
Q1 2020 21,479,335 +1,474,260 +7.4% 30 Apr 2020 10-Q 09 Jun 2020 2020 Q2
Q4 2019 20,841,309 +1,371,074 +7% 31 Jan 2020 10-Q 09 Mar 2020 2020 Q1
Q3 2019 20,331,754 +1,423,122 +7.5% 31 Oct 2019 10-K 07 Jan 2021 2020 FY
Q2 2019 20,162,851 +1,466,705 +7.8% 31 Jul 2019 10-Q 06 Sep 2019 2019 Q3
Q1 2019 20,005,075 +3,154,630 +19% 30 Apr 2019 10-Q 12 Jun 2019 2019 Q2
Q4 2018 19,470,235 +2,839,044 +17% 31 Jan 2019 10-Q 13 Mar 2019 2019 Q1
Q3 2018 18,908,632 +2,305,873 +14% 31 Oct 2018 10-K 09 Jan 2020 2019 FY
Q2 2018 18,696,146 +3,575,907 +24% 31 Jul 2018 10-Q 07 Sep 2018 2018 Q3
Q1 2018 16,850,445 +5,155,582 +44% 30 Apr 2018 10-Q 11 Jun 2018 2018 Q2
Q4 2017 16,631,191 +7,873,141 +90% 31 Jan 2018 10-Q 09 Mar 2018 2018 Q1
Q3 2017 16,602,759 +7,850,372 +90% 31 Oct 2017 10-K 11 Jan 2019 2018 FY
Q2 2017 15,120,239 +6,372,486 +73% 31 Jul 2017 10-Q 08 Sep 2017 2017 Q3
Q1 2017 11,694,863 +2,955,204 +34% 30 Apr 2017 10-Q 26 May 2017 2017 Q2
Q4 2016 8,758,050 +27,172 +0.31% 31 Jan 2017 10-Q 16 Mar 2017 2017 Q1
Q3 2016 8,752,387 +27,509 +0.32% 31 Oct 2016 10-K 09 Jan 2018 2017 FY
Q2 2016 8,747,753 +26,875 +0.31% 31 Jul 2016 10-Q 19 Aug 2016 2016 Q3
Q1 2016 8,739,659 -210,192,531 -96% 30 Apr 2016 10-Q 20 May 2016 2016 Q2
Q4 2015 8,730,878 -210,981,312 -96% 31 Jan 2016 10-Q 19 Feb 2016 2016 Q1
Q3 2015 8,724,878 -63,298 -0.72% 31 Oct 2015 10-K 08 Dec 2016 2016 FY
Q2 2015 8,720,878 -228,101,312 -96% 31 Jul 2015 10-Q 18 Aug 2015 2015 Q3
Q1 2015 218,932,190 -490,000 -0.22% 30 Apr 2015 10-Q 22 May 2015 2015 Q2
Q4 2014 219,712,190 +9,194,660 +4.4% 31 Jan 2015 10-Q 09 Mar 2015 2015 Q1
Q3 2014 8,788,176 -200,488,569 -96% 31 Oct 2014 10-K 23 Dec 2015 2015 FY
Q2 2014 236,822,190 +30,646,001 +15% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 219,422,190 +19,532,394 +9.8% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 210,517,530 +25,413,493 +14% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 209,276,745 +24,297,708 +13% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 206,176,189 +30,045,142 +17% 31 Jul 2013 10-Q/A 20 Sep 2013 2013 Q3
Q1 2013 199,889,796 +18,425,149 +10% 30 Apr 2013 10-Q/A 19 Jun 2013 2013 Q2
Q4 2012 185,104,037 +4,648,900 +2.6% 31 Jan 2013 10-Q/A 25 Mar 2013 2013 Q1
Q3 2012 184,979,037 +8,847,990 +5% 31 Oct 2012 10-K/A 17 Jan 2014 2013 FY
Q2 2012 176,131,047 +3,974,740 +2.3% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 181,464,647 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 180,455,137 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 176,131,047 +22,386,609 +15% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 172,156,307 31 Jul 2011 10-Q/A 14 Oct 2011 2011 Q3
Q3 2010 153,744,438 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.